Lightpath Tech Inc (LPTH) 1.65 $LPTH LightPath Joins

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 8:04 AM

Lightpath Tech Inc (LPTH) 1.65 $LPTH

LightPath Joins Nanomaterial Innovation Limited as Key Industrial Partner on National Science Foundation Phase II SBIR Program
Marketwired - Wed Jun 29, 8:00AM CDT
ORLANDO, FL--(Marketwired - Jun 29, 2016) - LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath", the "Company" or "we"

, a leading vertically integrated global manufacturer, distributor and integrator of proprietary optical and infrared components and high-level assemblies, today announced it has won a $200,000 sub-award from the National Science Foundation for a Phase II Small Business Innovation Research titled "Carbide bonded graphene coating for enhanced glass molding." LightPath is part of the research team led by the primary grantee of Nanomaterial Innovation Limited (NIL), a spin-off from The Ohio State University.
LPTH: 1.65 (+0.01)

LightPath Technologies Launches Updated Global Website
Marketwired - Thu Jun 09, 8:00AM CDT
ORLANDO, FL--(Marketwired - Jun 9, 2016) - LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath", the "Company" or "we"

, a leading vertically integrated global manufacturer, distributor and integrator of proprietary optical and infrared components and high-level assemblies, today announced the successful launching of its redesigned corporate website.
LPTH: 1.65 (+0.01)

LightPath Technologies Reports 29% Revenue Increase With Fiscal 2016 Third Quarter Financial Results
Marketwire Canada - Thu May 05, 3:01PM CDT
Revenue Diversification and Gross Margin Improvement Drive Operating Income Growth
LPTH: 1.65 (+0.01)

LightPath Technologies Announces Addition of New Director to Board
Marketwired - Tue May 03, 10:00AM CDT
LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," or "we"

, a leading vertically integrated global manufacturer, distributor and integrator of proprietary optical components and high-level assemblies, today announced it has appointed Mr. Craig Dunham to its Board of Directors (the "Board"

, effective April 28, 2016. An experienced photonics executive, Mr. Dunham will also serve on LightPath's audit committee. Mr. Dunham will fill a vacancy created by the Board when it expanded its size from seven to eight directors. With the addition of Mr. Dunham, the Company's Board will have eight directors, seven of whom are independent as defined by the NASDAQ Listing Rules.
LPTH: 1.65 (+0.01)

LightPath Technologies Schedules Fiscal 2016 Third Quarter Financial Results Conference Call for May 5
Marketwired - Mon Apr 25, 9:30AM CDT
LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company" or "we"

, a leading vertically integrated global manufacturer, distributor and integrator of proprietary optical and infrared components and high-level assemblies, today announced the scheduling of its fiscal 2016 third quarter financial results press release issuance and the corresponding conference call and simultaneous webcast. The press release will be issued on May 5, 2016 after the close of the stock market.
LPTH: 1.65 (+0.01)

LightPath Technologies Reports 26% Revenue Increase With Fiscal 2016 Second Quarter Financial Results
Marketwired - Thu Feb 04, 3:01PM CST
LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company" or "we"

, a leading vertically integrated global manufacturer, distributor and integrator of proprietary optical and infrared components and high-level assemblies, today announced financial results for the fiscal 2016 second quarter ended December 31, 2015.
LPTH: 1.65 (+0.01)

The Zacks Analyst Blog Highlights: Transmontaigne Partners, LightPath Technologies, Teekay LNG Partners, Arotech and AngloGold Ashanti
Zacks Equity Research - Zacks Investment Research - Tue Feb 02, 8:30AM CST
The Zacks Analyst Blog Highlights: Transmontaigne Partners, LightPath Technologies, Teekay LNG Partners, Arotech and AngloGold Ashanti
TGP: 10.84 (+0.34), ARTX: 2.98 (+0.10), AU: 20.84 (+0.84), TLP: 41.36 (+0.59), LPTH: 1.65 (+0.01)

5 Best Performing Stocks in January (Revised)
Swarup Gupta - Zacks Investment Research - Tue Feb 02, 8:06AM CST
Markets had a particularly dismal January, primarily due to a slump in oil prices and concerns about China's economy.
AMZN: 745.81 (+9.24), GE: 32.20 (+0.38), AU: 20.84 (+0.84), C: 41.98 (+0.69), WFC: 47.79 (+0.99), BAC: 13.17 (+0.16), LPTH: 1.65 (+0.01), BA: 130.09 (+2.92), MS: 26.37 (+0.68), NFLX: 97.06 (+1.96), T: 42.61 (+0.31), JPM: 61.83 (+1.25), IBM: 154.46 (+1.86), ARTX: 2.98 (+0.10), MSFT: 52.30 (+0.92), VZ: 55.90 (+0.52), AAPL: 96.68 (+0.74)

5 Best Performing Stocks in January
Swarup Gupta - Zacks Investment Research - Mon Feb 01, 12:49PM CST
Markets had a particularly dismal January, primarily due to a slump in oil prices and concerns about China's economy.
AVID: 6.11 (+0.20), NFLX: 97.06 (+1.96), AMZN: 745.81 (+9.24), GE: 32.20 (+0.38), JPM: 61.83 (+1.25), IBM: 154.46 (+1.86), ARTX: 2.98 (+0.10), C: 41.98 (+0.69), BAC: 13.17 (+0.16), WFC: 47.79 (+0.99), LPTH: 1.65 (+0.01), MSFT: 52.30 (+0.92), BA: 130.09 (+2.92), AAPL: 96.68 (+0.74), VZ: 55.90 (+0.52), MS: 26.37 (+0.68)

LightPath Technologies Announces Preliminary Results for Fiscal 2016 Second Quarter Financial Results
Marketwired - Mon Feb 01, 8:39AM CST
LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company" or "we"

, a leading vertically integrated global manufacturer, distributor and integrator of proprietary optical and infrared components and high-level assemblies, today announced preliminary financial results for the fiscal 2016 second quarter ended December 31, 2015 and the scheduling of a conference call and simultaneous webcast on February 4, 2016 to discuss the Company's financial and operational results for such period.
LPTH: 1.65 (+0.01)

LightPath Technologies Adjourns Annual Meeting Until February 25
Marketwired - Thu Jan 28, 1:03PM CST
LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company" or "we"

, a leading vertically integrated global manufacturer, distributor and integrator of proprietary optical and infrared components and high-level assemblies, announced today that its Annual Meeting of Shareholders scheduled for January 28, 2016 has been adjourned to February 25, 2016 at 11:00 am ET, and will take place at the Company's offices at 2603 Challenger Tech Court, Suite 130, Orlando, FL 32826. The adjournment period will allow for the continued solicitation of proxies from shareholders with respect to Proposal 2, the proposal to increase the board size from seven to twelve directors, and Proposal 3, the proposal to modify the percentage of shareholder votes needed to change the board size, from 85% to a majority of shares represented.
LPTH: 1.65 (+0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...